You just read:

AcelRx Pharmaceuticals Provides Guidance on 2017 Milestones for ARX-04, now known as DSUVIA™ in the United States, for the Treatment of Moderate-to-Severe Acute Pain

News provided by

AcelRx Pharmaceuticals, Inc.

Jan 08, 2017, 08:02 ET